FDA
approval
· 2022-12-22
FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for the fixed-dose combination diclofenac sodium and misoprostol from Mylan Pharmaceuticals Inc. The approval updates th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DICLOFENAC SODIUM AND MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL)